The Von Hippel-Lindau Disease Market is estimated to be valued at USD 301.2 million in 2024 and is expected to reach USD 510.3 million by 2031, growing at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2031. https://logcla.com/blogs/436467/Von-Hippel-Lindau-Disease-Therapeutics-Market-is-Expected-to-Grow